|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,973.50 JPY | -2.35% |
|
-1.39% | -8.04% |
| 08/05 | UK's MHRA approves Dawnzera for treatment of familial chylomicronemia syndrome | RE |
| 01/05 | Otsuka's Profit Jumps 15% in Q1 | MT |
| Capitalization | 1,155B 7.35B 6.24B 5.71B 5.39B 10.05B 701B 10.13B 67.77B 26.45B 334B 27.59B 27.01B | P/E ratio 2026 * |
18.2x | P/E ratio 2027 * | 16.9x |
|---|---|---|---|---|---|
| Enterprise value | 886B 5.64B 4.79B 4.38B 4.13B 7.71B 537B 7.77B 51.98B 20.29B 256B 21.16B 20.72B | EV / Sales 2026 * |
0.68x | EV / Sales 2027 * | 0.63x |
| Free-Float |
59.17% | Yield 2026 * |
3.11% | Yield 2027 * | 3.3% |
| 1 day | -2.40% | ||
| 1 week | -1.39% | ||
| Current month | +2.54% | ||
| 1 month | +0.34% | ||
| 3 months | -4.01% | ||
| 6 months | -2.27% | ||
| Current year | -8.04% |
| 1 week | 2,971 |  | 3,077 |
| 1 month | 2,827.5 | | 3,158 |
| Current year | 2,827.5 | | 3,308 |
| 1 year | 2,815 | | 3,353 |
| 3 years | 2,565 | | 3,789 |
| 5 years | 1,845 | | 3,789 |
| 10 years | 1,031.25 | | 3,789 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuji Otsuka
PSD | President | 72 | 01/08/2001 |
Koichi Hisano
CMP | Compliance Officer | - | - |
Minoru Sakurai
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/03/2013 |
| Director | Title | Age | Since |
|---|---|---|---|
Yuji Otsuka
BRD | Director/Board Member | 72 | 01/03/1992 |
| Director/Board Member | 73 | 01/03/1997 | |
| Director/Board Member | 75 | 01/03/2002 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +13.67% | 0.2% | 77 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.35% | -1.39% | -0.80% | +15.42% | 7.36B | |
| -1.92% | -5.66% | -45.53% | -21.72% | 22.52B | |
| -2.50% | -3.16% | -13.62% | +21.82% | 16.56B | |
| -0.97% | +4.07% | +34.65% | +48.46% | 9.28B | |
| +2.27% | +2.90% | -2.84% | +84.93% | 4.26B | |
| -1.08% | +4.20% | +128.86% | +231.01% | 3.72B | |
| -2.84% | -3.11% | +43.61% | +184.94% | 3.66B | |
| -0.65% | +3.02% | -0.32% | -28.86% | 2.15B | |
| -1.90% | +3.40% | +14.08% | +17.42% | 2.01B | |
| +2.39% | +8.89% | +19.28% | +68.54% | 1.5B | |
| Average | -0.95% | +2.04% | +17.74% | +62.20% | 7.3B | |
| Weighted average by Cap. | -1.61% | -0.74% | -3.44% | +33.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,309B 8.34B 7.08B 6.48B 6.11B 11.4B 795B 11.49B 76.86B 30B 378B 31.29B 30.63B | 1,372B 8.74B 7.42B 6.79B 6.4B 11.94B 833B 12.04B 80.55B 31.44B 397B 32.79B 32.1B |
| Net income | 63.31B 403M 342M 313M 295M 551M 38.41B 555M 3.72B 1.45B 18.29B 1.51B 1.48B | 68.28B 435M 369M 338M 319M 594M 41.43B 599M 4.01B 1.56B 19.73B 1.63B 1.6B |
| Net Debt | -269B -1.71B -1.45B -1.33B -1.26B -2.34B -163B -2.36B -15.79B -6.16B -77.76B -6.43B -6.29B | -289B -1.84B -1.56B -1.43B -1.35B -2.52B -175B -2.54B -16.98B -6.63B -83.57B -6.91B -6.77B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/05/26 | 2,973.50 ¥ | -2.35% | 333,100 |
| 11/05/26 | 3,045.00 ¥ | +0.23% | 1,652,900 |
| 08/05/26 | 3,038.00 ¥ | +0.80% | 2,410,200 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4768 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition